Expired Australian patentAustralia
Preparation and use of a specific gaba-A alpha 5 receptor ligand for treatment of Alzheimers disease
AU 1996047257 · Applicant: Merck Sharp & Dohme Limited
Overview
Drawings and full text
Its specification, documents and status are on IP Australia's AusPat.
Open the AusPat recordRead the whole patent
Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 20, 1996 and granted September 30, 1999. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by February 20, 2017.
- A pharmaceutical extension adds at most five years, so even that would have ended by February 20, 2022.
- We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 20, 1996
GrantedSeptember 30, 1999
Term ended byFebruary 20, 2017
Application numberAU 1996047257
Classification (IPC)G01N33/15 +2 more
Timeline
Timeline From IP Australia dates
Sources & verification
Official IP Australia records
Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.